The research question was to investigate whether non-surgical periodontal therapy could reduce cardiovascular risk markers in Coronary heart disease (CHD) patients.
Age range
35 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
change in fibrinogen level between baseline and 3 months after non-surgical periodontal treatment
Timeframe: 3 months after non-surgical periodontal treatment
change in activator inhibitor 1 between baseline and 3 months after non-surgical periodontal treatment
Timeframe: 3 months after non-surgical periodontal treatment
change in C-reactive protein between baseline and 3 months after non-surgical periodontal treatment
Timeframe: 3 months after non-surgical periodontal treatment
change in fibrinogen level between baseline and 6 months after non-surgical periodontal treatment
Timeframe: 6 months after non-surgical periodontal treatment
change in activator inhibitor 1 between baseline and 6 months after non-surgical periodontal treatment
Timeframe: 6 months after non-surgical periodontal treatment
change in C-reactive protein between baseline and 6 months after non-surgical periodontal treatment
Timeframe: 6 months after non-surgical periodontal treatment